JPMorgan Chase Boosts Stake in Spire Healthcare
JPMorgan Chase & Co., a multinational investment bank and financial services company, has made significant changes to its holdings in Spire Healthcare Group PLC. According to a TR-1 notification filed with the London Stock Exchange on October 1, 2026, JPMorgan Chase & Co. acquired additional shares of Spire Healthcare Group PLC.
The notification reveals that as of September 28, 2026, JPMorgan Chase & Co. held 3.9228% of voting rights in Spire Healthcare Group PLC through its subsidiary, J.P. Morgan Securities PLC. This represents a significant increase from the previous holding of 1.0042%.
The acquisition was made through cash-settled equity swaps, with several swap agreements set to expire between January and November 2027. The exact number of shares acquired is not disclosed in the notification.